PMC:7352545 / 71521-72675
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T694 | 0-6 | Body_part | denotes | Plasma | http://purl.org/sig/ont/fma/fma62970 |
| T695 | 267-273 | Body_part | denotes | plasma | http://purl.org/sig/ont/fma/fma62970 |
| T696 | 1013-1021 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T697 | 1035-1038 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T698 | 1039-1046 | Body_part | denotes | genomes | http://purl.org/sig/ont/fma/fma84116 |
| T699 | 1098-1101 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
| T700 | 1141-1144 | Body_part | denotes | RNA | http://purl.org/sig/ont/fma/fma67095 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T276 | 122-127 | Disease | denotes | Ebola | http://purl.obolibrary.org/obo/MONDO_0005737 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1034 | 0-6 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | Plasma |
| T1035 | 82-85 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T1036 | 267-273 | http://purl.obolibrary.org/obo/UBERON_0001969 | denotes | plasma |
| T1037 | 389-394 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T1038 | 395-405 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
| T1039 | 705-710 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T1040 | 859-864 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T1041 | 1007-1012 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T1042 | 1064-1065 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T1043 | 1135-1140 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T52765 | 351-360 | Chemical | denotes | molecules | http://purl.obolibrary.org/obo/CHEBI_25367 |
| T58339 | 411-420 | Chemical | denotes | alkaloids | http://purl.obolibrary.org/obo/CHEBI_22315 |
| T419 | 445-455 | Chemical | denotes | terpenoids | http://purl.obolibrary.org/obo/CHEBI_26873 |
| T44677 | 476-481 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T42308 | 582-587 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T422 | 630-634 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T423 | 903-905 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
| T424 | 906-908 | Chemical | denotes | TM | http://purl.obolibrary.org/obo/CHEBI_55460|http://purl.obolibrary.org/obo/CHEBI_74861 |
| T37578 | 909-912 | Chemical | denotes | Ser | http://purl.obolibrary.org/obo/CHEBI_17115|http://purl.obolibrary.org/obo/CHEBI_29999 |
| T428 | 1013-1021 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T130 | 749-759 | http://purl.obolibrary.org/obo/GO_0004175 | denotes | proteinase |
| T131 | 1109-1118 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T692 | 0-73 | Sentence | denotes | Plasma sera prepared from infected patients is an alternative medication. |
| T693 | 74-164 | Sentence | denotes | The WHO has suggested this trial since the 2014 Ebola epidemic and 2015 MERS-CoV outbreak. |
| T694 | 165-208 | Sentence | denotes | In addition, Mab therapy is another option. |
| T695 | 209-336 | Sentence | denotes | For example, LCA50 Mab mimics produced by modification of plasma antibodies isolated from MERS-CoV patients was valuable [140]. |
| T696 | 337-456 | Sentence | denotes | Low molecular molecules are being examined for anti-virus activities from alkaloids, glycan derivatives and terpenoids. |
| T697 | 457-560 | Sentence | denotes | Recently, anti-CoV drugs are being approached using molecular modeling, docking and simulation methods. |
| T698 | 561-692 | Sentence | denotes | Computation-assisted drugs via molecular modeling and docking toward drug targets are applied as anti-viral compounds against CoVs. |
| T699 | 693-728 | Sentence | denotes | They target human ACE2, PLpro (PDB: |
| T700 | 729-765 | Sentence | denotes | 3e9s), the CoV main proteinase (PDB: |
| T701 | 766-933 | Sentence | denotes | 6Y84), 3-chymotrypsin-like (3C-like protease; 3CLpro), RdRp, helicase, N7 methyltransferase, human DDP4, RBD, protease cathepsin L, type II TM Ser protease or TMPRSS2. |
| T702 | 934-950 | Sentence | denotes | CoV 3CLpro (PDB: |
| T703 | 951-1022 | Sentence | denotes | 6WX4) and the PLpro cleave the polyproteins to assemble virus proteins. |
| T704 | 1023-1154 | Sentence | denotes | For newborn RNA genomes, RdRp is used as a replicase for the complementary RNA strand synthesis, which uses the virus RNA template. |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32604730-30684561-51944107 | 331-334 | 30684561 | denotes | 140 |
| T85859 | 331-334 | 30684561 | denotes | 140 |